Lv11
66 积分 2023-02-09 加入
Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2
4小时前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
3个月前
已完结
CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells
3个月前
已完结
TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer
3个月前
已完结
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
4个月前
已完结
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial
4个月前
已完结
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
4个月前
已完结
Towards precision oncology with patient-derived xenografts
4个月前
已完结
Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises
4个月前
已完结
CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells
4个月前
已完结
皖公网安备34019202002308
